以岭药业品牌怎么样 申请店铺

我要投票 以岭药业在中草药行业中的票数:826 更新时间:2026-02-19
以岭药业是哪个国家的品牌?「以岭药业」是 石家庄以岭药业股份有限公司 旗下著名品牌。该品牌发源于河北,由创始人吴相君在2001期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力以岭药业品牌出海!将品牌入驻外推网,定制以岭药业品牌推广信息,可以显著提高以岭药业产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

以岭药业怎么样

国家重点高新技术企业--石家庄以岭药业股份有限公司由中国工程院吴以岭院士创建,在他的领导下,以岭药业始终坚持以科技为先导,以市场为龙头的科技创新发展战略,创立"理论-科研-新药-生产-营销"五位一体的独特运营模式,建立起以中医络病理论创新为指导的新药研发创新技术体系。

在以岭药业的发展历程中,凝聚了一大批科研、管理、生产、营销精英,包括归国专家、外籍专家、博士、硕士及各类高职人才,为河北医科大学培养博士、硕士研究生,被国家人事部批准为博士后科研工作站。

以岭药业以络病理论创新带动中医药产业化,运用现代高新技术研发现代中药、西药、和生物药,研发国家专利新药9个,覆盖心脑血管疾病、感冒呼吸疾病、肿瘤、糖尿病及其并发症等重大疾病领域。通过国家GMP认证的中药生产线、通过欧盟认证的化学制剂生产车间具有年产值达50亿的生产能力。以岭药业为国家创新型企业、中国制药工业50强,以岭商标成为中国驰名商标。

国家科技部前领导曾赞誉五位一体的发展模式为"我国中医药科技成果产业化的创举"。

以岭药业立足国内、接轨国际,在石家庄、北京大兴、密云建立了三个国际标准的科研生产基地,通过了欧盟、新西兰等GMP认证。科研、生产、质检、贸易、管理人才全部具有国际化背景,构建了符合国际药品标准的生产、质控体系。依靠现代高新技术与设备和完善的药品生产质量控制体系,生产高品质中药与西药。产品已经出口到英国、美国、西班牙、韩国、日本、俄罗斯、新西兰等许多国家。

位于北京生物工程与医药产业基地的北京以岭药业,占地210亩,为国家重点高新技术企业,主要生产面向国际市场的植物药、保健品、膳食补充剂。

位于北京密云的北京以岭生物按照欧美GMP标准建设,主要生产面向国际市场的激素、肿瘤类药物和具有自主知识产权的新制剂。

Shijiazhuang Yiling Pharmaceutical Co., Ltd, a national key high-tech enterprise, was founded by Academician Wu Yiling of Chinese Academy of engineering. Under his leadership, Yiling pharmaceutical always adheres to the development strategy of scientific and technological innovation with science and technology as the guide and market as the leader, creates a unique operation mode of "theory research new medicine production marketing" and establishes a theoretical innovation of traditional Chinese medicine collateral disease as the reference New drug R & D innovation technology system. In the development process of Yiling pharmaceutical industry, a large number of scientific research, management, production and marketing elites, including returned experts, foreign experts, doctors, masters and all kinds of higher vocational talents, have been gathered, training doctors and masters for Hebei Medical University, and approved by the Ministry of human resources as post doctoral research workstation. Lingyao promotes the industrialization of traditional Chinese medicine with the innovation of collateral disease theory, develops modern Chinese medicine, western medicine and biological medicine with modern high and new technology, and develops 9 new national patent drugs, covering the major disease fields such as cardio cerebrovascular disease, cold and respiratory disease, tumor, diabetes and its complications. The production line of traditional Chinese medicine certified by national GMP and the chemical production workshop certified by European Union have an annual output value of 5 billion. Take Ling pharmaceutical as a national innovative enterprise and top 50 pharmaceutical industry in China, and take Ling trademark as a well-known trademark in China. Former leaders of the Ministry of science and technology of the people's Republic of China once praised the five in one development mode as "the pioneering work of industrialization of scientific and technological achievements of traditional Chinese medicine". Based on domestic and international standards, Yiling pharmaceutical has established three international standard research and production bases in Shijiazhuang, Beijing Daxing and Miyun, and has passed GMP certification of EU, New Zealand, etc. The talents of scientific research, production, quality inspection, trade and management all have international background, and the production and quality control system in line with international drug standards has been established. Relying on modern high-tech and equipment and perfect quality control system of drug production, we can produce high-quality traditional Chinese medicine and Western medicine. The products have been exported to the United Kingdom, the United States, Spain, South Korea, Japan, Russia, New Zealand and many other countries. Located in Beijing bioengineering and pharmaceutical industry base, Beijing Yiling pharmaceutical, covering an area of 210 mu, is a national key high-tech enterprise, which mainly produces plant medicine, health care products and dietary supplements for the international market. Beijing Yiling biology, located in Miyun, Beijing, is built in accordance with European and American GMP standards. It mainly produces hormones, tumor drugs and new preparations with independent intellectual property rights for the international market.

本文链接: https://brand.waitui.com/887854f10.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

福特公布通用电动车平台的工程细节,旨在推出3万美元电动皮卡

福特公布了其通用电动车平台的工程细节,旨在推出一款约3万美元的中型电动皮卡。该车空气动力学性能比竞争对手好15%,采用48伏架构、磷酸铁锂方形电池,并使用大型一体式铸件以减少零件数量和组装时间。(新浪财经)

26分钟前

富时罗素拟修订“快速纳入”规则,为SpaceX、OpenAI等巨型IPO进场铺路

当地时间2月18日,富时罗素就潜在的快速上市规则及罗素美国股票指数资格标准的更广泛调整征询市场意见,以应对2026年预期中的多项大型IPO,包括SpaceX、OpenAI和Anthropic。根据现行规则,新股仅在季度审查时纳入,且须满足全部资格要求,包括至少5%的流通股比例及至少5%的公众投票权。市场预期显示,部分未来IPO可能无法达到这些最低标准。因此本次咨询同时提出快速纳入机制及调整最低流通量与投票权要求的方案,以适应这些大规模发行。(界面)

26分钟前

2026年电影票房破50亿

36氪获悉,据网络平台数据,截至2月19日11时12分,2026年电影票房(含预售实时)突破50亿元。

26分钟前

太初元碁完成智谱GLM-5.0及阿里千问双开源模型深度适配

36氪获悉,2月18日晚,“太初元碁“完成多款国产主流开源大模型的深度适配工作,其中包括智谱GLM-5.0、阿里千问Qwen3.5-397B-A17B。据了解,太初元碁的国产大模型适配均在其自研T100加速卡上进行,在主流大模型适配过程中,针对不同开发者的技术能力差异,太初元碁在SDAA软件栈中推出了阶梯式开发工具链,全面覆盖从入门到高阶的多元化开发需求,该工具链能够帮助开发者快速构建高性能算子,实现与主流AI生态的无缝兼容,显著降低CUDA生态迁移的技术门槛与成本。

26分钟前

法国国家银行账户档案系统遭非法访问

当地时间2月18日,法国经济和财政部在一份公报中指出,自2026年1月底起,有人冒用一名公务员的登录凭证,查阅了国家银行账户档案系统约120万个账户的内容。查阅内容包含个人数据、银行账户信息、账户持有人身份信息、地址以及纳税识别号。法国经济和财政部表示,相关部门“已全面动员”应对此次事故。(央视新闻)

26分钟前

本页详细列出关于以岭药业的品牌信息,含品牌所属公司介绍,以岭药业所处行业的品牌地位及优势。
咨询